Novel mitochondrial transition pore inhibitor N-methyl-4-isoleucine cyclosporin is a new therapeutic option in acute pancreatitis by Tóth, Emese et al.
Tóth et al, 1 
 
Novel mitochondrial transition pore inhibitor N-methyl-4-isoleucine cyclosporin is a new 1 
therapeutic option in acute pancreatitis 2 
Emese Tóth,1,2 József Maléth,1,3 Noémi Závogyán,1 Júlia Fanczal,1,3 Anna Grassalkovich,1,2 3 
Réka Erdős,1 Petra Pallagi,1,3 Gergő Horváth,4 László Tretter,4 Emese Réka Bálint,5 Zoltán 4 
Rakonczay Jr.,5 Viktória Venglovecz,6 Péter Hegyi2,7,8
 
5 
 6 
1First Department of Medicine, University of Szeged, Szeged, Hungary  7 
2Momentum Translational Gastroenterology Research Group, Hungarian Academy of 8 
Sciences–University of Szeged, Szeged, Hungary  9 
3Momentum Epithelial Cell Signalling and Secretion Research Group, Hungarian Academy of 10 
Sciences–University of Szeged, Szeged, Hungary  11 
4Department of Medical Biochemistry, Semmelweis University, Budapest, Hungary 12 
5Department of Pathophysiology, University of Szeged, Szeged, Hungary   13 
6Department of Pharmacology and Pharmacotherapy, University of Szeged, Szeged, Hungary  14 
7Institute for Translational Medicine and First Department of Medicine, University of Pécs, 15 
Pécs, Hungary,  16 
8Szentágothai Research Centre, University of Pécs, Pécs, Hungary   17 
Corresponding author: Prof. Peter Hegyi, Institute for Translational Medicine, University of 18 
Pécs, 7624 Pecs, Szigeti út 12., hegyi2009@gmail.com, p.hegyi@tm-centre.org   19 
  20 
Tóth et al, 2 
 
KEYPOINTS 21 
Bile acids, ethanol and fatty acids deteriorate pancreatic ductal fluid and bicarbonate secretion 22 
via mitochondrial damage, ATP depletion and calcium overload. 23 
 It is known that pancreatitis inducing factors open the membrane transition pore (mPTP) 24 
channel via cyclophilin D activation in acinar cells causing calcium overload and cell death and  25 
genetic or pharmacological inhibition of mPTP improves the outcome of acute pancreatitis in 26 
animal models. 27 
In our study we show that genetic and pharmacological inhibition of mPTP protects 28 
mitochondrial homeostasis and cell function evoked by pancreatitis-inducing factors in 29 
pancreatic ductal cells. 30 
Our results also reveal that the novel Cyclosporin A derivative NIM811 protects mitochondrial 31 
function in acinar and ductal cells, moreover it preserves bicarbonate transport mechanisms in 32 
pancreatic ductal cells. 33 
We found that NIM811 is highly effective in different experimental pancreatitis models and 34 
that NIM811 has no side-effects.  NIM811 is a highly suitable compound to be tested in clinical 35 
trials . 36 
 37 
ABSTRACT 38 
Background and aims  39 
Mitochondrial dysfunction plays a crucial role in the development of acute pancreatitis (AP); 40 
however, no compound is currently available with clinically acceptable effectiveness and 41 
safety. In this study, we investigated the effects of a novel mitochondrial transition pore 42 
inhibitor, N-methyl-4-isoleucine cyclosporin (NIM811), in AP. 43 
Methods 44 
Pancreatic ductal and acinar cells were isolated by enzymatic digestion from Bl/6 mice. In vitro 45 
measurements were performed by confocal microscopy and microfluorometry. Preventive 46 
effects of pharmacological (cylosporin A (2µM), NIM811 (2µM)) or genetic (Ppif−/−/Cyp D 47 
KO) inhibition of the mitochondrial transition pore (mPTP) during the administration of either 48 
bile acids (BA) or ethanol + fatty acids (EtOH+FA) were examined. Toxicity of mPTP 49 
inhibition was investigated by detecting apoptosis and necrosis. In vivo effects of the most 50 
promising compound, NIM811 (5 or 10 mg/kg per os), were checked in three different AP 51 
models induced by either caerulein (10x50µg/kg), ethanol+ fatty acid (1.75 g/kg ethanol and 52 
750 mg/kg palmitic acid) or 4% taurocholic acid (2ml/kg).  53 
 54 
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Results  55 
Both genetic and pharmacological inhibition of Cyp D significantly prevented the toxic effects 56 
of BA and EtOH+FA by restoring mitochondrial membrane potential (Δψ) and preventing the 57 
loss of mitochondrial mass. In vivo experiments revealed that per os administration of NIM811 58 
has a protective effect in AP by reducing oedema, necrosis, leukocyte infiltration and serum 59 
amylase level in AP models. Administration of NIM811 had no toxic effects. 60 
Conclusion  61 
The novel mitochondrial transition pore inhibitor NIM811 seems to be an exceptionally good 62 
candidate compound for clinical trials in AP.  63 
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INTRODUCTION  68 
Acute pancreatitis (AP) is among the most common gastrointestinal disorders requiring 69 
hospitalization in the United States (Fangenholz et al,2007 ; Fagenholz et al, 2007  ; Peery et 70 
al ,2012 )  . Although the disease is generally mild, the mortality rate in its severe form is still 71 
unacceptably high (Parniczky et al, 2016). In recent years, our understanding of the mechanisms 72 
that play a crucial role in the development of the disease has improved (Abu-El-Haija et al , 73 
2018) . Impaired autophagy, trypsinogen activation, excessive Ca2+ influx, calcineurin 74 
activation, mitochondrial dysfunction and cystic fibrosis transmembrane conductance regulator 75 
(CFTR) inhibition were shown to have a great impact in the early phase of AP. Therefore, 76 
targeting one of these mechanisms may lead to the first specific therapy in AP. 77 
Among the mechanisms noted above, one of the earliest events in AP is mitochondrial 78 
dysfunction (Sah and Saluja,2011; Maleth et al, 2013; Abu-El-Haija et al, 2018 ; Biczo and 79 
Vegh et al ,2018 ;)  . It has been shown in acinar cells that bile acids (BA) and ethanol and fatty 80 
acids (EtOH+FA) open the membrane transition pore (mPTP) channel via cyclophilin D (Cyp 81 
D) activation, keeping the channel continuously opened and thus resulting in mitochondrial 82 
depolarization, lower ATP synthesis and cell necrosis (Shalbueva et al, 2013; Mukherjee et al, 83 
2016; Abu-El-Haija et al, 2018 )  . Although it is still unknown how the pancreatitis-inducing 84 
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factors noted above modify mPTP channel activity in pancreatic ductal epithelial cells (PDEC), 85 
it still seems to be one of the most promising drug targets and calls for further investigation.   86 
Until now, cyclosporin A (CyA) is the only licenced compound used experimentally to 87 
inhibit mPTP (via Cyp D) (Javed et al, 2018); however, its clinical usefulness is highly 88 
questionable for several reasons. A pilot study found that CyA could  reduce the size and 89 
damage of myocardial infarction, but larger studies showed no beneficial effects (Piot et 90 
al,2008; Cung et al,2015; Javed et al, 2018) . Even efforts to decrease its immunosuppressive 91 
activity have not been successful. Moreover, CyA derivative Debio025 (Alispovirir, 92 
Debiopharm) has been found effective against the hepatitis C virus (HCV), but it had serious 93 
side-effects. Surprisingly, some of the patients developed pancreatitis, resulting in a clinical 94 
hold on the global Debio025 trial programme (Zeuzem et al,2015; Stanciu et al, 2019). Another 95 
derivative, TRO40303 (3,5-seco-4-nor-cholestan-5-one oxime-3-o, TROPHOS, Roche), was 96 
not beneficial in a phase 2 trial of cardiac preservation following acute myocardial infarction, 97 
suggesting that this compound has low or no effectivity (Atar et al, 2015) . Lately, it has turned 98 
out that TRO40303 does not even bind to Cyp D directly (Sileikyte,2016 ; Javed et al, 2018;)  . 99 
With regard to AP, both Debio025 and TRO40303 have been shown to be beneficial in animal 100 
models, but neither of them have reached “proof of concept” clinical trials in AP, most probably 101 
due to the clinical failures noted above. All in all, new compounds are crucially needed.  102 
A novel cyclosporin A derivative, N-methyl-4-isoleucine cyclosporin (NIM811), was 103 
found to be highly beneficial in different experimental and clinical studies. NIM811 was 104 
effective in animal models of central nervous system injury (Readnower et al, 2011) , allergic 105 
encephalomyelitis (Huang et al, 2017), ischaemic-reperfusion injury after surgical intervention 106 
(Garbaisz et al,2014)  ,hepatitis C (Arai et al,2014) , liver transplantation (Rehman et al, 2011)  107 
and pulmonary injury during liver transplantation (Liu et al, 2012) . Importantly, none of the 108 
studies reported side-effects. NIM811 had no severe or serious adverse effects in a phase 2 109 
clinical trial on HCV-infected patients, suggesting that NIM811 has no toxic 110 
immunosuppressant activity either (Lawitz et al, 2011).  111 
In this study, we show in several in vitro and in vivo experiments that either 112 
pharmacological or genetic inhibition of Cyp D restores mitochondrial function not only in 113 
acinar cells, but also in ductal cells, highlighting the general importance of mPTP in AP. 114 
Moreover, we provide evidence that NIM811 is highly effective in different experimental 115 
pancreatitis models and that NIM811 has no side-effects.   116 
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MATERIALS AND METHODS 117 
Ethical approval 118 
The animal experiments were performed in compliance with European Union Directive 119 
2010/63/EU and Hungarian Government Decree 40/2013 (II.14.). Experiments were approved 120 
by local ethics committees for investigations involving animals at the University of Szeged  121 
(XII/4988/2015). In our study all animals were euthanized by 200 mg/kg pentobarbital i.p. 122 
(Bimeda MTC, Cambridge, Canada).  123 
Animals 124 
A total of 70 wild type (WT) and cyclophilin D knockout (Cyp D KO, (B6;129-Ppiftm1Maf/J) 125 
mice were sacrificed. Cyp D KO mice were generated by targeted disruption of the Ppif gene 126 
(which encodes the Cyp D that is a component of the mPTP) (Baines et al, 2005). Cyp D KO 127 
animals were provided for us by the Department of Medical Biochemistry, Semmelweis 128 
University, Budapest, Hungary. Wild type and Cyp D-deficient littermate mice (of C57Bl/6 J 129 
background, either sex, aged between 20 and 45 days) were housed in a room maintained at 130 
20–22°C on a 12 h light–dark cycle with food and water available ad libitum. To ensure a 131 
homologous genetic background, mice were backcrossed with C57Bl6/J mice for at least eight 132 
generations.  133 
 134 
Solutions and chemicals 135 
Chemicals were obtained from Sigma-Aldrich (Budapest, Hungary), unless otherwise stated. 136 
2.7-bis-(2-carboxyethyl)-5-(and-6-) carboxyfluorescein-acetoxymethylester (BCECF-AM) and 137 
Tetramethylrhodamine-methylester (TMRM) were purchased from Termofischer Scientific .  138 
NIM811 were purchased from MedChem Express Europe (Sweden). Cyclosporin A (CYA) , 139 
caerulein (CER) , NIM811, CCCP and fluorescence dies were diluted in dimethyl sulfoxide 140 
(DMSO) . Table 1 describes the constitution of solutions that we used during the study. In this 141 
study 500µM Chenodeoxycholic acid (bile acid,BA) or 100mM ethanol (EtOH) + 200µM 142 
palmitoleic acid (fatty acid, FA) was used during the fluorescence, confocal microscopy and 143 
immunostaining measurements, to evaluate the effect of bile acids or the alcohol and fatty acid 144 
induced damage on the mitochondrial and cell function during the genetic or pharmachological 145 
inhibition of the mPTP in pancreatic ducts or acinar cells. 100 µM of Carbonyl cyanide 3-146 
chlorophenylhydrazone (CCCP) were used in the mitochondrional measurements as a positive 147 
control for mitochondrial damage.  148 
Tóth et al, 6 
 
 2 µM CYA and 2 µM NIM811 were used to pharmacologically inhibit mPTP. Prior to the 149 
fluorescence and confocal microscopy, immunostainings, the cells (ducts and acinar cells as 150 
well) from the CYA- or NIM811- treated groups were pretreated for 25-30 minutes with the 151 
compounds (CYA or NIM811).  152 
Abbrevations used in this study:  153 
AP- acute pancreatitis , NIM811- N-metil-izoleucine cyclosporine , mPTP- mitochondrial 154 
transition pore , mitochondrial membrane potencial- ψ, CFTR- cystic fibrosis transmembrane 155 
conductance regulator, PDEC-pancreatic ductal epithelial cells , Cyclophylin D- Cyp D ,  156 
CYA- cylosporin A , Hepatitis C virus-HCV, Debio025- Alispovirir, Tro40303-3,5-seco-4-nor-157 
cholestan-5-one-oxime-3-o, PCR-polymerase chain reaction, TMRM- 158 
Tetramethylrhodamine Methyl Ester Perchlorate, TOM20- Mitochondrial import 159 
receptor subunit, FA- fatty acid (palmitoliec acid ), FAEE- Fatty acid ethyl ester ,  ETOH- 160 
ethanol , BA- CDC- chenodeoxycholic acid , BCECF-AM (2',7'-Bis-(2-Carboxyethyl)-5-161 
(and-6)-Carboxyfluorescein, Acetoxymethyl Ester), CER-caerulein , TAU- sodium 162 
taurocholate , TBS-  Tris Buffered Solution, BSA- Bovine Serum Albumin, HBSS- Hank1s 163 
Stock Solution, CBD- Common Pancreatic Biliary Duct, CCCP- Carbonyl cyanide 3-164 
chlorophenylhydrazone 165 
 166 
Methods 167 
Mouse genotyping  168 
Genotypes of cyclophilin D deficient mice were identified by PCR (typical polymerase 169 
chain reaction , analyses from tail genomic DNA) . PCR-mix contained: Taq DNA pol 5 U and  170 
10xTaq Buffer (Abgene, Portmouth, USA), MgCl2 1,5 mM, dNTP 2.5mM, F-171 
null2/LoxP1f /CyPuP2  primers (20-20µM), dH2O and template DNA sample. Total reactions 172 
mix volume was 25 µl. 173 
The wild type allele was detected using LoxP1f,  5’-AAA CTT CTC AGT CAG CTG TTG 174 
CCT CTG-3’ as a forward primer and F-null2, 5’- GCT TTG TTA TCC CAG CTG GCG C-3’ 175 
as a reverse primer. For genotyping of the mutant cyclophilin D deficient allele,  F-null2, 5’-176 
TTC TCA CCA GTG CAT AGG GCT CTG –3’ was used as a forward primer with the reverse 177 
primer for WT (Table 2. ) . DNA was denatured at 95°C for 2 mins, followed by 30 cycles of 178 
amplification: 94°C for 30 secs, 60°C for 30 secs, 72°C for 45 secs and a final primer extension 179 
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step at 72°C for 7 mins. Bands of 270 and 470 base pairs were amplified for WT and CypDKO 180 
mice, respectively.  181 
Pancreatic ducts and acinar cells were isolated by microdissection and enzymatic 182 
digestion as described earlier (Argent et al,1986 ; Gout et al, 2013) (Argent, Arkle et al. 1986, 183 
Gout, Pommier et al. 2013).  184 
Mitochondrial membrane potential (Ψ) were determined by Zeiss LSM 880 confocal 185 
laser scanning microscope (Carl Zeiss Technika Kft., Budaörs, Hungary). BA or EtOH + FA 186 
were used to induce mitochondrial damage. Isolated pancreatic ducts or acinar cells were 187 
incubated in standard HEPES solution and loaded with TMRM (Tetramethylrhodamine 188 
Methyl Ester Perchlorate ,100 nmol/L). 189 
In order to monitor apoptotic and necrotic cells in isolated pancreatic ducts or acinar 190 
cells an apoptosis/necrosis kit was used (ab176750, Abcam). To determinate  live, necrotic or 191 
apoptotic cells, CytoCalcein Violet 450 fluorescent, Apopxin Deep Red Indicator  and Nuclear 192 
Green DCS1 fluorecence dies (ab176750, Abcam) were used. Samples were incubated in the 193 
mixture of the above stated fluorescence dyes at room temperature for 30-35 mins (after 25 min 194 
treatment of with BA/ETOH+FA/CYA/NIM811) in dark prior to the confocal microscopy 195 
measuremets. In case of CYA or NIM811 treated ducts or acinar cells, the incubation with these 196 
compounds were performed before staining with the fluorescence dyes . Stainings were 197 
analyzed using a Zeiss LSM 880 confocal laser scanning microscope (Carl Zeiss Technika Kft., 198 
Budaörs, Hungary). Live, necrotic or apoptotic cells were counted and summarized in 199 
percentage of each sample, then data were summarized to average and statistical analysis was 200 
performed.  201 
Microfluorometry was used to measure pancreatic ductal HCO3
- secretion as described 202 
earlier (Hegyi et al, 2003, Hegyi et al, 2004) by using BCECF-AM (2',7'-Bis-(2-203 
Carboxyethyl)-5-(and-6)-Carboxyfluorescein, Acetoxymethyl Ester , 1.5 mmol/L). 204 
Functionally active mitochondria were detected with immunofluorescent staining 205 
(TOM20 mitochondrial marker, (EPR15581-39, Abcam)). In order to determine mitochondrial 206 
localisation in isolated pancreatic ductal or acinar cells we labeled the mitochondria by the 207 
using of TOM20 primary antibody ( Abcam, EPR15581-39). TOM20 is the central unit of the 208 
receptor TOM complex in the mitochondrial outer membrane and the role of it is to recognise 209 
and translocate cytosolically synthetized mitochondrial preproteins (Shatz et al,1996; 210 
Pfanner,1998; Rapaport,2002). Isolated pancreatic ducts were frozen in cryomold at 20◦C. The 211 
cryosections (thickness 7 µm) of the isolated pancreatic ducts from WT and Cyp D KO mice 212 
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were cut by Leica Cryostat. Sections  were fixed in 4% paraformaldehyde . Washing periods 213 
were administered with 1xTBS solution.  Antigen retrieval was performed with 10 mM Sodium 214 
–Citrate solution at the pH of 6  at 95 ◦C for 15 minutes. Blocking was obtained for 1h with 1% 215 
goat serum in 5% BSA-TBS solution. After these sections were incubated with TOM20 rabbit 216 
monoclonal antibody (dilution 1:400,Abcam) overnight incubation at 4◦C. The following day 217 
the samples were incubated with goat anti rabbit secondary antibody (Alexa fluor 488, Thermo 218 
Fisher, Rockford, IL, United States) for 2 hours at dark in room temperature. The nuclei were 219 
counterstained with Hoechst 33342 (Termofischer, Rockford,IL,United States) . 220 
Immunofluorescence staining of the isolated  pancreatic acinar cells were performed freshly 221 
after the isolation procedure with the same conditions as stated above, (except two parameters 222 
; cells were fixed in 2% paraformaldehyde and dilution fo the primary antibody was 1:200) as 223 
stated above. Both ductal and acinar cell samples were mounted with Fluoromount and then 224 
analyzed using a Zeiss LSM 880 confocal laser scanning microscope (Carl Zeiss Technika Kft., 225 
Budaörs, Hungary). To quantify TOM20 positively stained area, 5-6 representative images 226 
from each group were taken by Zeiss LSM 880 Confocal Scannig Microscope (Carl Zeiss 227 
Technika Kft., Budaörs, Hungary). Image J software was used to convert images to gray scale 228 
(16 bit), threshold function was used to select the positively stained area. The fluorescence 229 
signal were calculated by the software (arbitary scale from 0-negative (white) to 255-maximal 230 
staining (black)) (Venglovecz et al,2018). Fluorescence intensity of the images were then 231 
normalized to the own total ductal or acinar area of the samples, which were measured in 232 
arbitary units.  Fluorescence intensity was given in %, normalized to the total ductal or acinar 233 
total area.  234 
AP was induced by caerulein (CER,10x50µg/kg); 4% sodium taurocholate (TAU, 235 
2ml/kg,4%) (Niederau et al, 1985 ; Ding et al,2003 ; Perides et al,2010; Pallagi and Balla et 236 
al;2014 ;) or alcohol and fatty acid (intraperitonal injection of 1.75 g/kg ethanol and 750 mg/kg 237 
palmitic acid , EtOH+FA) as described earlier (Huang et al.,2014;Maleth et al, 2015). All 238 
control groups received physiological saline in the same amount as the CER, EtOH+FA or the 239 
TAU solutions respectively. Pre-treatment of the animals by NIM811 was performed  and mice 240 
were gavaged orally once 1 h prior to the induction AP, concentrations of NIM811 were 10 241 
mg/kg or 5mg/kg. Dosage of NIM811 was chosen according to a previous study in which 242 
NIM811 was effective against mitochondrial damage in liver transplantation (Rehman et al, 243 
2011). Oral gavage treatment were performed by the use of plastic feeding tubes (20ga x 38mm, 244 
Instech Laboratories, USA). NIM811 were solubilized in a vehicle which contained 8.3% 245 
polyoxyl 40 hydrogenated castor oil and 8.3% ethanol (Rehman et al, 2011)  .  246 
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NIM811 was used as a post-AP treatment as well. NIM811 was administered 12 hour 247 
after the induction of AP in the TAU or EtOH+FA induced experimental pancreatitis models. 248 
Concerning the CER induced AP, NIM811 was administered after the 3rd injection of CER.  249 
The method for retrograde intraductal infusion of TAU has been described by Perides et al 250 
(Perides et al, 2010)  . The surgery was performed on anesthetized mice (with ketamine-251 
xylazine, dosage: 87.5 mg/kg ketamine-12.5 mg/kg xylazine). At the end of the procedure the 252 
mice were placed on a heating pad for 40 minutes and received buprenorphine i.p. injection 253 
(0.075 mg/kg) at once to reduce their occurrent pain. Following these mice were replaced into 254 
their cages for 24hours. They had free access to food and water. 24 hours after the TAU or 255 
EtOH +FA induced AP the mice were euthanized by 200 mg/kg pentobarbital i.p. (Bimeda 256 
MTC, Cambridge, Canada), . During the CER induced AP mice were euthanized with 200 mg/ 257 
kg pentobarbital i.p. (Bimeda MTC, Cambridge, and Canada) 2 hours after the last injections 258 
of CER.   Mice were exsanguinated through cardiac puncture and the pancreas were removed. 259 
Blood from the cardiac puncture was placed on ice, then centrifuged with 2500 RCF for 15 260 
mins at 4°C. Blood serum was collected from the pellet and stored at -20°C until use. Pancreas 261 
samples were placed into 8% neutral formaldehyde solution and stored at -4°C until the 262 
hematoxylin –eosin staining was performed. A colorimetric kit was used to measure serum 263 
amylase activity (Diagnosticum, Budapest, Hungary). Absorbance of the samples were detected 264 
at 405 nm with the use of FLUOstar OPTIMA (BMG Labtech, Budapest, Hungary) microplate 265 
reader. Formaldehyde-fixed pancreas samples were embedded in paraffin and were cut into 3 266 
μm thick sections and stained for hematoxylin-eosin by using a standard laboratory method. To 267 
quantify oedema, necrosis and leukocyte infiltration grades a semiquantitative scoring system 268 
was used as Kui et al described previously (Kui and Balla et al, 2015) . 269 
In vitro pancreatic ductal fluid secretion (luminal swelling) assays were developed by 270 
Fernández-Salazar et al, (Fernández-Salazar et al,2004) performed by videomicroscopy as 271 
described earlier (Balázs et al,2018). Briefly, stimulaton of pancreatic ductal fluid secretion 272 
was induced by 5 µM forskolin and 100 µM 3-isobutyl-1-methylxanthine (IBMX) , 273 
quantification were performed by Image J Software (Balázs et al,2018). In vivo fluid secretion 274 
measurements were performed on anesthetized (by i.p. 87.5 mg/kg ketamine-12.5 mg/kg 275 
xylazine ) mice after CER or EtOH+FA induced AP prior to euthanasia.  Animals were placed 276 
on warm pads (37◦ C) to maintain the body temperature. Briefly, the abdomen of the mice were 277 
opened and cannucaltion of the lumen of the common biliopancreatic duct was performed by a  278 
30-gauge needle (Maléth et al, 2015). Then the proximal end of the common duct was closed 279 
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by a microvessel clip (Braun-Aesculap, Tuttlingen, Germany) to prevent contamination with 280 
bile, and the pancreatic juice was collected in PE-10 tube for 15 min. In vivo secretion was 281 
induced by i.p. administration of 0.75CU/kg secretin (Maléth et al, 2015).   282 
 283 
Statistical Analysis 284 
All data are expressed as means ± SEM. Data were compared by either one- or two-way analysis 285 
of variance (ANOVA) or Kruskal–Wallis tests followed by the Holm–Sidak Method as 286 
appropriate (Sigma Plot). The effects were considered significant when p < 0.05.  287 
 288 
 289 
RESULTS 290 
 291 
Genetic inhibition of mPTP protects mitochondrial homeostasis and cell function evoked 292 
by pancreatitis-inducing factors in PDEC 293 
First, we measured the effects of the most relevant pancreatitis-inducing factors on 294 
mitochondria in primary intact ducts isolated from Ppif−/− and WT mice. Experiments 295 
performed with TMRM and TOM20 revealed that genetic inhibition of mPTP decreased both 296 
the loss of Δψ (Fig. 1A) and mitochondrial mass (Fig. 1B) caused by 500 µM CDC (BA) or co-297 
administration of 100mM ethanol and 200µM palmitoleic acid (EtOH+FA). Co-staining the 298 
pancreatic ducts with CytoCalcein Violet, Apopxin Deep Red and Nuclear Green showed that 299 
genetic inhibition of mPTP also decreased the extent of necrosis and apoptosis during the 300 
administration of BA or EtOH+FA (Fig. 1C), suggesting that genetic inhibition of Cyp D has a 301 
protective effect on PDEC. Next, we investigated how the genetically preserved mitochondrial 302 
function affects the cellular function of PDEC (Fig. 1D). We used the NH4Cl pulse technique, 303 
which is uniquely suited to characterizing both HCO3
- influx and efflux mechanisms. Our 304 
experiments demonstrated that the inhibitory effects of BA and EtOH+FA on Cl/HCO3
- 305 
exchangers (HCO3
- efflux) and on Na/HCO3
- co-transporters (HCO3
- influx) are totally blocked 306 
in Ppif−/− vs WT mice, suggesting that inhibition of mPTP can preserve ductal function and thus 307 
has therapeutic benefits (Fig. 1D–F).   308 
 309 
Pharmacological inhibition of mPTP by CyA effectively prevents mitochondrial damage 310 
evoked by pancreatitis-inducing factors in PDEC 311 
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Both BA and EtOH+FA significantly decreased the ψ of PDEC (Fig. 2A). Importantly, 2µM 312 
CYA effectively blocked the toxic effects of the BA- and EtOH+FA-preserving function of 313 
mitochondria during the presence of pancreatitis-inducing factors. As regards the quantity of 314 
mitochondria, CYA effectively inhibited loss, as we could see during the genetic inhibition of 315 
mPTP (Fig. 2B). 2µM CYA decreased the extent of necrosis and apoptosis during the 316 
administration of BA or EtOH+FA in PDEC (Fig. 2C). Finally, we provided strong evidence 317 
of the beneficial effects of CYA on mPTP noted above, mitochondrial mass and cell death, 318 
resulting in preserved HCO3
-efflux and influx mechanisms during BA or EtOH-FA 319 
administration (Fig. 2D–F).  320 
 321 
NIM811 treatment protects mitochondrial function and preserves bicarbonate transport 322 
mechanisms in PDEC  323 
Next, we investigated the effects of the novel CYA derivative NIM811 on mitochondrial 324 
function and of bicarbonate secretion on isolated pancreatic ducts. According to our data, 325 
NIM811 reduces the BA- or EtOH+FA-induced damage to mitochondrial function and 326 
morphology in isolated pancreatic ducts (Fig. 3A–B). Experiments using CytoCalcein Violet, 327 
Apopxin Deep Red and Nuclear Green showed that NIM811 alone has no toxic effects on 328 
PDEC. Furthermore, it can strongly decrease BA- or EtOH-FA-evoked necrosis and apoptosis 329 
(Fig. 3C). NH4Cl
- experiments revealed that the inhibitory effects of BA and EtOH+FA on 330 
Cl/HCO3
- exchangers (HCO3
- efflux) and on Na/HCO3
- co-transporters (HCO3
- influx) were 331 
significantly reduced in the NIM811-treated groups compared to the controls, showing a 332 
protective effect of NIM811 on PDEC (Fig. 3D). 333 
 334 
NIM811 and CYA have no effects on pancreatic ductal fluid secretion 335 
Both in vivo and in vitro measurements revealed that NIM811 or CyA treatment can not prevent 336 
BA or EtOH+FA induced fluid secretiory damage in isolated ducts (Fig.4 A-D, E-F).  337 
 338 
NIM811 treatment protects mitochondrial function in acinar cells  339 
In vitro measurements of freshly isolated pancreatic acinar cells showed that NIM811 treatment 340 
decreased the BA- and EtOH-FA-induced loss of ψ as effectively as we have seen in PDEC 341 
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(Fig. 4A). However, results obtained from TOM20 staining suggest that NIM811 has no effect 342 
on mitochondrial mass in acinar cells (Fig. 5B). Microfluorometric measurements demonstrated 343 
that NIM811 alone has no toxic effects on acinar cells and has no effect on BA- or EtOH-FA-344 
induced apoptosis, but is protective against BA- or EtOH-FA-induced necrosis (Fig. 5C). 345 
 346 
NIM811 has therapeutic benefits in caerulein, taurolithocholic acid sulfate and ethanol 347 
and fatty acid induced AP  348 
Firstly, we confirmed that per os administration of either 5 or 10mg/kg NIM811 alone has no 349 
toxic effect on the pancreas (Fig 9.) . Secondly, we tested the compound in three different 350 
experimental AP models, the caerulein (CER) , alcohol and fatty acid (EtOH+FA) and the 351 
taurocholic (TAU)-induced ones (Niederau et al,1985; Huang et al, 2014; Perides et al,2010)  . 352 
Importantly, both pretreatment 5 or 10mg/kg NIM811 significantly reduced the elevation of 353 
serum amlylase activity, as well as pancreatic oedema, necrosis and leukoctye infiltration in  354 
experimental AP models (Figs. 6–8). In our study we also confirmed, that post treatment of 355 
5mg/kg or 10 mg/kg NIM811 has protective effects against pancreatic damage (Figs. 6-8.). 356 
  357 
DISCUSSION 358 
Acute pancreatitis is a multifactorial disease (Hegyi and Petersen ,2013; Sahin-Toth and 359 
Hegyi, 2017 )  involving several types of cell, including acinar and ductal cells. None of the 360 
therapeutic efforts targeting only one of them have been successful. Intravenous administration 361 
of secretin, which targeted ductal cells only, was found either to be slightly beneficial or natural 362 
in AP (Renner et al,1983; Lankisch et al, 1983; Keim et al, 1985). On the other hand, neither 363 
gabexate mesilate nor trasylol, which effectively inhibit trypsin activity, had beneficial effects 364 
in AP (Imrie et al,1978; Buchler et al, 1993) (Imrie, Benjamin et al. 1978, Buchler, 365 
Malfertheiner et al. 1993). Therefore, we need to find common targets which can restore both 366 
acinar and ductal cell functions in AP.     367 
Mitochondrial damage is one of the key pathophysiological events in the early phase of 368 
AP in both types of cell (Maleth et al, 2013; Hegyi and Petersen, 2013 ; Maleth and Hegyi,2016) 369 
It decreases ATP production, causing elevation of intracellular calcium concentration; 370 
moreover, it negatively influences ATP-dependent Cl-HCO3
- exchangers, CFTR Cl- channels 371 
in ductal cells and enzyme secretory processes in acinar cells (Maleth et al,2011; Maleth et al, 372 
Tóth et al, 13 
 
2013 ; Judak et al, 2014; Maleth et al,2015 ; Mukherjee et al,2016; Maleth and Hegyi,2016, 373 
Biczo and Vegh et al, 2018 ). In addition, mitochondrial damage is the main factor in 374 
determining cell death pathways necrosis and apoptosis. Release of mitochondrial cytochrome 375 
c into the cytosol causes apoptosis, whereas mitochondrial depolarization leads to necrosis 376 
(Odinokova et al, 2008) . Generally, the standard apoptotic pathway involves mitochondrial 377 
outer membrane permeabilization, which causes apoptotic factors like cytochrome c to be 378 
released from the inner membrane to the cytosol (Tait et al, 2010; Maleth et al, 2016 ). On the 379 
other hand, the opening of the mPTP leads to loss of ψ , ATP depletion, increased inner 380 
membrane permeability, mitochondrial swelling and necrotic cell death (Golstein et al, 2007; 381 
Halestrap et al, 2009; Maleth et al, 2016). Very uniquely, inhibition of mPTP could prevent 382 
both cell death mechanisms in PDEC, which is different from that seen in acinar cells, where 383 
only necrosis could have been prevented. All in all, inhibition of mPTP seems to be highly 384 
beneficial in both cell types. In the last decade, it has been proved that genetic or 385 
pharmacological inhibition of mPTP reduces BA- or EtOH+FA-induced AC damage as well as 386 
augmenting the severity of AP (Sah et al,2011; Mukherjee et al, 2016 ; Gukovskaya et al, 2016; 387 
Biczo and Vegh et al,2018). As regards ductal cells, we have shown earlier that both BA and 388 
EtOH+FA induce inhibition of HCO3
- secretion via severe mitochondrial damage in PDEC)  389 
(Maleth et al,. 2011, Maleth et al. 2015). Now, we have continued our experiments investigating 390 
the role of mPTP and its inhibition in this type of epithelial cell. First, we characterized the role 391 
of mPTP (both genetic and pharmacological CyA) inhibition in PDEC and found that its 392 
inhibition has a strong protective effect against the toxic effects of BA or EtOH+FA in ductal 393 
cells, suggesting that targeting mPTP may have general benefits. Although many mPTP 394 
inhibitors have been tested, none of them have been successful. CyA itself inhibits calcineurin, 395 
which leads to immunosuppressant activity and thus could negatively affect the treatment of 396 
patients due to hazardous infections. Clinical testing of non-immunosuppressive CyA 397 
derivatives Debio025 and TRO40303 was also stopped before reaching the “proof of concept” 398 
phase 2 clinical trials in AP because of its inconsistent behavior in other trials due to the facts 399 
noted in the introduction. Recently, other new mPTP inhibitors have been introduced in 400 
experimental studies. Isoxazoles had inconsistent effects in myocardial infarction (Sileikyte et 401 
al, 2016 ). Benzamides resulted in impaired ATP generation (Sileikyte et al, 2016; Javed et al, 402 
2018)  . Cinnamic anilides were shown to be effective in myocardial infarction (Fancelli et al, 403 
2010) ; however, lately it has turned out that it has an age-related toxicity (Fang et al, 2019). 404 
Besides unsuccessful attempts, NIM811 seemed to be a perfect choice . It has been shown to 405 
be protective in several diseases, and until now no toxic effects have been demonstrated. 406 
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Therefore, we continued our study by testing the effects of NIM811 on both ductal and acinar 407 
cells in vitro. We found that NIM811 reduces the mitochondrial damage caused by BA or 408 
EtOH+FA . Importantly, NIM811 decreased apoptosis levels during BA or EtOH+FA treatment 409 
in ductal cells, but not in acinar cells, a result which could be due to the observation that ductal 410 
cells have more mitochondria than acinar cells (Maleth et al, 2013). Surprisingly, inhibition of 411 
mPTP protected pancreatic ductal bicarbonate but fluid secretion during BA or EtOH+FA 412 
treatment. These data suggest that rescuing intracellular ATP level and the activity of Na+/K+-413 
ATPase do not result in overall protection alone and other fluid transport mechanisms such as 414 
aquaporins may remain diminished (Venglovecz et al, 2018). Per os administration of 5 or 10 415 
mg/kg NIM811 treatment alone had no toxic effect, but significantly reduced the severity of 416 
AP. We found that NIM811 treatment was more beneficial in the TAU than the EtOH+FA 417 
induced AP model. One of the explanations could be that besides the direct toxic effect of EtOH 418 
and FA, the non-oxidative metabolites of FA namely FAEE has even higher toxicity on the 419 
mitochondria both in acinar and ductal cells (Criddle et al, 2006; Petersen et al, 2009). 420 
Taken together, mitochondrial function and bioenergetics play a crucial role in the 421 
development of AP; however, translation of the results to patient benefit is still missing (Maleth 422 
et al,2013 ;Mukherjee et al,2016 ;Maleth and Hegyi,2016 ; Gukovskaya et al, 2016; Biczo and 423 
Vegh et al,2018). In this study, we were the first to confirm that the mPTP inhibitor NIM811 is 424 
a highly suitable compound to be tested in clinical trials. As a next step, the companies should 425 
organize phase 2 clinical trials with the use of this novel and promising drug candidate. 426 
   427 
FIGURES AND FIGURE LEGENDS 428 
Figure1. Genetic inhibition of Cyp D reduces the severity of bile acid or ethanol and fatty 429 
acid induced damage in PDEC 430 
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 431 
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Mitochondrial membrane potencial measurements revealed that genetic inhibition of mPTP 432 
significantly reduces the mitochondrial membrane potencial loss compared to WT controls 433 
during the administration of bile acid (500 µm CDC) or ethanol (100mM) and fatty acid 434 
(200µM FA) treatment (Fig1. A) ( WT control vs WT BA ***p<0.001,WT BA vs Cyp D KO 435 
BA **p<0.002, WT control vs Cyp D KO BA p=07.12,WT control vs. WT EtOH+FA p<0.01, 436 
WT EtOH+FA vs KO ETOH+FA * p<0.05, WT control vs Cyp D KO EtOH+FA p=0.145) n=4-437 
6 experiments/group, data means ±SEM. Results from the immunostainings revealed a 438 
significant decrease of the TOM20 stainings in BA; EtOH+PA or CCCP treated WT ducts , 439 
results were compared to Cyp D KO stainings . (Fig1.B) (*p<0.05). Genetic inhibition of mPTP 440 
also decreased the necrosis and apoptosis levels during bile acid; ethanol or fatty acid or CCCP 441 
treatment (Fig1.C). (*p<0.05)  442 
Representative traces  from the pancreatic ductal HCO3- secretion measurements  (Fig.1.D) Our 443 
data revealed that recovery from the alkalosis grades were significantly lower due to BA or 444 
ETOH+FA administration (*p<0.05) compared to the results from  Cyp D KO ducts (Fig1.E). 445 
Recovery from the acidosis grades were significantly lower in the WT ducts due to the treatment 446 
with BA or EtOH and FA (*p<0.05 ), while in Cyp D KO ducts these grades were significantly 447 
higher (*p<0.05) .  n=5-7 experiments/group, data means ±SEM. 448 
  449 
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Figure2. CYA reduces the severity of bile acid or ethanol and fatty acid induced pancreatic 450 
ductal damage   451 
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 452 
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2 µM CYA treatment reduced the drop of mitochondrial membrane potencial loss which accured 453 
due to the BA or ETOH+FA treatment. (WT vs. CYA) (Fig.2.A). In WT ducts BA or ETOH+FA 454 
treatment resulted in significantly reduced mitochondrial membrane potencial (WT control vs 455 
WT BA *p<0.05, WT control vs WT EtOH +FA p<0.05), while between WT control groups 456 
compared to CYA treated BA or EtOH+FA there were no significant decrease. TOM20 levels 457 
were significantly reduced in BA; ETOH+FA or CCCP control (not CYA treated ) ducts, while 458 
in the CYA treated groups the percentage of TOM20 stained area were significantly higher 459 
(Fig2.B) *p<0.05. Between the control groups (WT control or only CYA treated samples) we 460 
found no significant alterations in the stainings. Necrosis levels were intensively elevated in 461 
BA or EtOH treated groups in WT ducts but not in CYA treated groups (Fig.2.C). Apoptosis 462 
levels were significantly higher as well in the not CYA treated groups compared to the CYA 463 
treated groups (Fig2. C).  464 
Measurements of HCO3- secretion levels revealed a significant difference in WT and CYA 465 
treated ducts during the administration of BA (p<0.05 WT BA vs CYA BA) or EtOH+FA  466 
(*p<0.05). In WT ducts the levels of base flux (-J(B-/min) grades were significantly decreased 467 
(Fig2.E,F) due to BA (WT vs WT BA p<0.05) or ETOH+FA (WT vs WT EtOH+PA p<0.05) 468 
treatment (Fig2 E,F). Recovery from alkalosis (Figure 2. E) and recovery from acidosis values 469 
are presented in base flux ((-J(B-/min) grades respectively, with ±SEM. Comparison within 470 
CYA treated groups revealed no significant difference (CYA control vs CYA BA p=0.644).  471 
  472 
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 473 
Figure3. NIM811 protects mitochondrial and cell function in PDEC 474 
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 475 
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 476 
NIM811 treated ducts revealed a significantly consolidated loss of mitochondrial membrane 477 
potencial during the BA (WT BA vs NIM811 BA *p<0.05) or ETOH+FA (WT ETOH+FA vs 478 
NIM811 ETOH+FA *p<0.05)  treatment (Fig.3A) . In NIM811 treated ducts the percentage of 479 
fluorescence intensity were significantly higher compared to not NIM811 treated ducts during 480 
BA or ETOH+FA administration. In CCCP treated ducts we found no significant difference in 481 
the amount of TOM20 stainings in the aspect of NIM811 treated or not treated groups. NIM811 482 
itself did not alter the value of TOM20 stainings compared to the WT control samples (Fig.3B).  483 
NIM811 decreased the numbers of apoptotic and necrotic cells during bile acid or ethanol and 484 
fatty acid treatment (Fig.3C) (WT BA vs NIM811 BA *p<0.05, WT EtOH+FA vs NIM811 485 
*p<0.05). While during the administration of CCCP the apoptosis and necrosis grades were not 486 
significantly different in the comparative groups (Fig.3.C).  487 
NIM811 treatment did not decreased the HCO3- secretion grades (control, Fig.3 D,E,F) , while 488 
during the adminsitration of BA or ETOH+FA treatment it had a protective effect  against the 489 
reduction of HCO3- secretory levels (Fig.3E/F) (WT BA vs NIM811 BA *p<0.05, WT 490 
EtOH+FA vs NIM811 EtOH+FA *p<0.05). In the aspect of recovery levels from alkali load 491 
during EtOH and FA treatment , the difference were not sigfnificant in WT EtOH+FA compared 492 
to the NIM811 and EtOH+FA treated groups (Fig.3E).  493 
  494 
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Figure 4. Pancreatic ductal fluid secretion is not altered by NIM811 or CYA treatment  495 
 496 
In vitro fluid secretion was stimulated by 5µM forskolin and 100µM IBMX (stimulation). BA 497 
or EtOH+PA treatment inhibited the luminal swelling (Fig.4.B-C). Figure 4D represents the 498 
relative luminal volume changes during forskolin and IBMX stimulation (Figure4.D). Means 499 
±SEM. n= 5-10 ducts/group. In vivo fluid secretion measurements were performed after the 500 
induction of CER or EtOH+FA induced AP (Fig.4.E-F.). These experiments confirmed that 501 
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pancreatic ductal fluid secretion is not affected by NIM811 or CyA. (Fig.4.E-F). *p<0.05 WT 502 
PS vs. WT EtOH+FA, ▪p<0.05 WT PS vs. WT CER n=4-7 animal/group 503 
  504 
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Figure5. NIM811 treatment protects mitochondrial function in pancreatic acinar cells 505 
 506 
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Mitochondrial membrane potencial measurements revealed a significant difference between 507 
WT not NIM811 treated and the NIM811 treated acinar cell response due to bile acid or ethanol 508 
and fatty acid treatment (Fig.5A) (WT BA vs NIM811 BA *p<0.05; WT EtOH+FA vs NIm811 509 
ETOH+FA * p<0.05). Significant difference was detected between the NIM811 treated acinar 510 
cells and the groups which were not treated with NIM811 (Fig.5A) during BA or ETOH+FA 511 
treatment. Mitochondrial protein TOM20 levels did not show difference in the NIM811 treated 512 
or not treated groups after BA, ETOH+FA or CCCP treatment (Fig.5B) (p>0.05). In necrosis 513 
levels we found significant difference between NIM811 treated and not treated groups in BA or 514 
ETOH+FA (Fig.5C) (*p<0.05). However, in CCCP treated groups we found no difference 515 
(Fig.5C). Apoptosis levels were not altered significantly by NIM811 during BA or ETOH+FA 516 
treatment.  517 
 518 
 519 
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Figure 6. NIM811 reduces the severity of CER induced AP520 
 521 
Serum amylase levels were elevated in the CER treated groups and NIM811 treatment resulted 522 
in a reduced serum amylase levels during CER induced AP compared to WT CER group (Fig. 523 
6B ***p<0.01 WT PS vs WT CER, **p<0.02 WT CER vs pre10mg/kg NIM811 CER, *p<0.05 524 
WT CER vs pre 5mg/kg NIM811 CER, p=0.717 CER+ pre 5mg/kg NIM811 vs CER + pre 525 
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10mg/kg NIM811 ). In the aspect of CER induced pancreatitis both 5 mg/bwkg NIM811 (Fig.6 526 
A-F, p<0.05 WT CER vs. pre 5mg/bwkg NIM811 CER) and pre 10 mg/bwkg NIM811 (Fig.6 527 
A-F, p<0.05 WT CER vs. Pre 10mg/bwkg NIM811 CER)) treatment reduced the CER-induced 528 
damage. Post 5mg/kg NIM811 treatment significantly reduced serum amylase levels compared 529 
to WT CER ▪▪p<0.05,  ▪▪▪p<0.001 WT PS vs WT CER (Fig.6G-E). Post insult administration 530 
of 10mg/kg NIM811 significantly reduced oedema and leukocyte infiltration levels compared 531 
to WT CER treated groups ▪▪p<0.05 (Fig.6H), n=8-10 animals per group, data means ±SEM).  532 
  533 
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Figure7. NIM811 reduces the severity of TAU induced AP in mice 534 
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 535 
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We performed TAU induced pancreatitis(Fig.7A-K), serum amylase measurements revealed 536 
that due to retrogrode infusion of TAU elevated serum amylase levels occured (***p<0.01 WT 537 
PS vs WT TAU Fig.6.B, ▪▪▪p<0.001 WT PS vs WT TAU Fig.7G) howewer 5 mg/bwkg or 10 538 
mg/bwkg NIM811 treatment significantly reduced the enzyme levels both in the pre and post 539 
treatment (Fig. 7B **p<0.02 WT TAU vs pre 5mg/kg NIM811+TAU , ** p<0.02 WT TAU vs 540 
pre 10mg/kg NIM811+TAU, , ▪▪▪p<0.001 WT TAU vs. post 5mg/kg NIM811 TAU,  ▪▪▪p<0.001 541 
WT TAU  vs post 10mg/kg NIM811 +TAU ) the serum amylase levels were reduced compared 542 
to WT TAU treated groups (Fig.7B. and 7G *p<0.01 WT TAU vs. WT 5mg/bwkg NIM811 543 
TAU and *p<0.01 WT TAU vs WT 10 mg/bwkg NIM811 TAU) . During pre NIM811 treatment 544 
oedema, necrosis and leukocyte infiltration scores were significantly decreased compared to the 545 
only TAU treated groups (Fig.7A,C,D,E p<0.05 WT TAU vs pre 5mg/bwkg NIM811 546 
TAU/10mg/bwkg NIM811 TAU). Post insult administration of NIM811 decreased oedema, 547 
leukocyte infiltration and necrosis levels in the TAU group (▪▪▪p<0.001 Fig.7G-K) n=4-6 548 
animals per group, data means ±SEM). 549 
 550 
  551 
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Figure8. NIM811 has protective effect against EtOH+FA induced pancreatic damage 552 
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 553 
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We performed EtOH+FA induced pancreatitis (Fig.8A-K). Serum amylase measurements 554 
revealed that in pre treatment of 10 mg/kg NIM811 significantly reduced serum amylase levels  555 
**p<0.002 WT EtOH+FA vs pre 10mg/kg NIM811 +EtOH+FA (Fig.8B), **p<0.002 WT PS vs 556 
Wt EtOH+FA (Fig.8B and G), in post NIM811 treatment serum amylase levels did not differ 557 
significantly compared to its ETOH+FA control (Fig.8G). In pre 10mg/kg  NIM811 treatment 558 
leukocyte infiltration (***p<0.001 WT EtOH+FA vs 10mg/kg NIM811) and necrosis levels 559 
(***p<0.001 Wt EtOH+FA vs 10 mg/kg NIM811) were significantly reduced compared to 560 
EtOH+FA AP group (Fig.8D-E). ***p<0.001 WT PS vs Wt EtOH+FA  in Fig.8C-E. Oedema 561 
and leukocyte infiltration levels were significantly reduced in post 5mg/kg NIM811 treated 562 
groups compared to WT EtOH+FA groups (*p<0.05 WT EtOH+FA vs post 5 mg/kg NIM811 ) 563 
(Fig.8H and K) n=4-7 animals per group, data means ±SEM).  564 
 565 
Figure9. NIM811 itself does not induce pancreatic damage  566 
 567 
No significant difference was found between the NIM811-treated - (8.3% Polyoxyl 40 568 
hydrogenated castor oil, 8.3% EtOH) vs. the control groups. n=4-5 animal/group  569 
  570 
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Table1. Solutions used in our study 571 
 HEPES 
(Standard) mM 
HCO3- 
(Standard) mM 
NH4Cl-HCO3- 
mM 
1xTBS mM HBSS 
(Standard) mM 
NaCl 140 115 95 150 0.137 
KCl 5 5 5 - 5.4 
CaCl2 1 1 1 - 0.3 
MgCl2 1 1 1 - - 
Glucose 10 10 10 - 6 
HEPES - - - - - 
NaHCO3- - 25 25 - 4.2 
NH4Cl- - - 20 - - 
Trisma Base - - - 50 - 
Na2HPO4 - - - - 0.25 
KH2PO4 - - - - 0.44 
MgSO4 - - - - 1.03 
 572 
 573 
Table 2. Oligonucleotide primers used in genotyping 574 
Primers 
F-null2 TTCTCACCAGTGCATAGGGCTCTG 
LoxP1f AAACTTCTCAGTCAGCTGTTGCCTCTG 
CyPuP2 GCTTTGTTATCCCAGCTGGCG 
 575 
 576 
  577 
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treatment. It is generally accepted, that one of the earliest events in the disease initiation is the 604 
mitochondrial dysfunction and ATP depletion. It has been shown that the pancreatitis-inducing 605 
factors namely ethanol, fatty acids and bile acids open the membrane transition pore (mPTP) 606 
channel, keeping the channel continuously opened resulting in mitochondrial depolarization, 607 
lower ATP synthesis and cell necrosis both in pancreatic acinar and ductal cells. In this study, 608 
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we provided strong evidence that one of the mPTP inhibitors, namely NIM811 is highly 609 
effective in different experimental pancreatitis models. Since NIM811 had no side-effects and 610 
passed the important phase 1 stage in the clinical trial process, companies should organize phase 611 
2 clinical trials with the use of this novel and promising drug candidate. 612 
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